Wearable Injectors Segmentation
The market is segmented on the basis of type into on-body and off-body, out of which the on-body segment is anticipated to grab the largest share by the end of 2030 on account of the increasing demand for this type of injector owing to the presence of multiple features. In addition, on-body wearable injectors are comfortable to be worn on the skin, along with their water-resistant capability and ease of use at home, which is also projected to contribute to the growth of the segment during the forecast period. Additionally, the off-body injector segment is also expected to grow significantly in the years to come as these devices reduce the problems such as adhesive fitting issues, painful removal and skin sensitivity.
Based on end-user, the home care settings segment in the wearable injectors market is projected to grow with a significant CAGR over the forecast period, which can be attributed to the surge in preference for self-administration of drugs and the rise in the development of advanced drug delivery options, which minimize the need for technical expertise while administering medications. Additionally, the restrictions posed by COVID-19 outbreak has also resulted in the rising adoption of self-administration of drugs in-home care settings, especially by the vulnerable groups such as the geriatric population, which is also expected to support the market growth.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
End-User |
|
